Physician profile
Robert Lynn Ward
NPI 1033155130
$203.59
in general payments reported to CMS, 2019-2025
9 companies · $115 in 2025
The $115 reported for 2025 was more than what 77% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $31.83 · 2023: $24.75 · 2024: $31.74 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.08 | 2023-2025 | Xifaxan |
| Braintree Laboratories, INC. | $29.16 | 2025 | Sutab, Suflave |
| Qol Medical, LLC | $24.74 | 2025 | Sucraid |
| Regeneron Healthcare Solutions, INC. | $19.65 | 2025 | Dupixent |
| Vertex Pharmaceuticals Incorporated | $19.39 | 2025 | |
| Csl Behring | $18.61 | 2022 | |
| Aimmune Therapeutics, INC. | $16.11 | 2024 | |
| Merck Sharp & Dohme LLC | $15.63 | 2024 | Bridion |
| Redhill Biopharma INC. | $13.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.